Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.14% | 3.27% | -1.90% | 3.87% | 23.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.14% | 3.27% | -1.90% | 3.87% | 23.21% |
| Cost of Revenue | 31.26% | 13.70% | 7.09% | -44.19% | -24.60% |
| Gross Profit | 5.82% | -7.90% | -12.54% | 161.81% | 204.22% |
| SG&A Expenses | 14.32% | 9.65% | -4.05% | -2.04% | 4.26% |
| Depreciation & Amortization | -1.77% | 1.41% | 0.55% | 9.73% | 3.64% |
| Other Operating Expenses | -95.35% | -100.48% | -92.30% | -32.39% | -0.38% |
| Total Operating Expenses | 4.18% | 0.43% | 0.61% | 2.72% | 14.26% |
| Operating Income | -0.24% | 0.43% | -1.38% | -2.40% | -11.98% |
| Income Before Tax | -5.60% | -4.32% | -4.06% | -2.29% | 20.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.60% | -4.32% | -4.06% | -2.29% | 20.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.63% | 7.76% | 5.87% | -2.25% | 6.38% |
| Net Income | -5.58% | -4.31% | -4.06% | -2.31% | 20.16% |
| EBIT | -0.24% | 0.43% | -1.38% | -2.40% | -11.98% |
| EBITDA | -0.68% | 1.95% | -0.25% | -0.27% | -11.41% |
| EPS Basic | 57.36% | 66.31% | 87.68% | 93.81% | 91.11% |
| Normalized Basic EPS | 59.20% | 67.52% | 87.87% | 93.72% | 90.97% |
| EPS Diluted | 57.38% | 66.32% | 87.68% | 93.81% | 91.10% |
| Normalized Diluted EPS | 59.20% | 67.52% | 87.87% | 93.72% | 90.97% |
| Average Basic Shares Outstanding | 128.88% | 161.63% | 237.08% | 415.47% | 978.30% |
| Average Diluted Shares Outstanding | 128.88% | 161.63% | 237.08% | 415.47% | 978.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |